Procurar
português
Iniciar sessão
Bemotrizinol - Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (BEMT) expecting approval by US FDA
The highly anticipated approval of Bemotrizinol (also known as BEMT or Tinosorb S) is expected to be announced by the United States Food and Drug Administration in 2026.
For over a decade, ALS has provided analytical method verification and routine batch release and stability testing of BEMT for our clients utilizing this over-the-counter drug in formulations sold in other countries.
Now that US FDA is ready to approve BEMT for use in the United States, our laboratory in Torrance is prepared to assist your brand with new formulations. ALS is ready with our proven validated method, experience, speed of service and quality, setting us apart other laboratories that are only now creating a method for this analysis.
In addition to offering analytical testing of BEMT, ALS is an end-to-end one-stop-shop providing clinical safety, clinical efficacy, microbiology, stability and toxicology testing for OTC and personal care products. We can assist your brand from the start of product formulation to routine batch release, enabling your products to get to market quicker.
Contact us at pharma.usa@alsglobal.com or at (310) 214-0043
ISO 23698: The Evolution of SPF Testing with a Hybrid Approach
Sun protection is essential to prevent damage caused by UV radiation, such as burns, premature aging, and skin cancer. Traditionally, the efficacy of sunscreens is measured by the Sun Protection Factor (SPF), using in vivo tests with human volunteers, with ISO 24444:2019 being the gold standard.